Stock 603087 GAN & LEE PHARMACEUTICALS.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Gan & Lee Pharmaceuticals.

Equities

603087

CNE100003ZH1

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
50.41 CNY +0.16% Intraday chart for Gan & Lee Pharmaceuticals. +0.74% -4.25%
Apr. 24 Gan & Lee Pharmaceuticals. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 24 Gan & Lee Pharmaceuticals. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Type 1 Diabetes Pipeline| Clinical Trials and Key Companies - Landos Biopharma, Diamyd Medical, Gan&Lee Pharmaceuticals, Zealand Pharma
AQ
Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for Investigational Drug, GZR18
AQ
Gan & Lee Pharmaceuticals : Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA)
AQ
Gan & Lee Pharmaceuticals : New Data on Phase 1 Proposed Biosimilar Gan & Lee Insulins Aspart (GL-ASP), Lispro (GL-LIS), and Glargine (GL-GLA) Presented at the American Diabetes Association's 81st Scientific Sessions
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 603087 Stock
  4. News Gan & Lee Pharmaceuticals.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW